AR
Aravive
ARAV·NASDAQHouston TXFounded 200815 employees
Micro CapbiotechPublicOncologyNephrology
Platform: AXL Inh Onc
Market Cap
$0.05B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (ARAV)
Loading ARAV stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Teratapinarof | ARA-2054 | Phase 3 | 1 | USP1 | RettOvarian Ca | ||
| ARA-160 | ARA-160 | Phase 1 | 1 | WRN | CeliacSCLC |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)